>> 全站文章索引 >> 第28页:
  • Functional Status and Lesion Location Predict Post-Stroke Depression: The Sunnybrook Stroke Study - [Black, Sandra E.; Singh, Anu; Herrmann, Nathan; Leibovitch, Farrell S.; Ebert, Patricia L.; Joanne, Lawrence; Szalai, John P.]
  • Relation between depression after stroke, antidepressant therapy, and functional recovery - [Gainotti, G.; Antonucci, G.; Marra, C.; Paolucci, S.]
  • Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging - [Carolyn Cidis Meltzer MD, Gwenn Smith Ph.D, Steven T DeKosky MD, Bruce G Pollock MD, Ph.D, Chester A Mathis Ph.D, Robert Y Moore MD, Ph.D, David J Kupfer MD and Charles F Reynolds III MD]
  • The water load test observations from healthy controls.pdf and patients with functional dyspepsia - [Jones MP, Hoffman S, Shah D, Patel K, Ebert CC.]
  • Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity - [M Ingelman-Sundberg1]
  • How psychotherapy changes the brain – the contribution of functional neuroimaging - [D E J Linden1,2]
  • Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders - [DMB Christmas, I Crombie, MS Eljamel, N Fineberg, R MacVicar, K Matthews, C Rück, C Stark]
  • Neuronal Dysfunction and Schizophrenia Symptoms - [Freedman R.]
  • The outcome of depressive disorders in neurology patients a prospective cohort study - [Carson AJ, Postma K, Stone J, Warlow C, Sharpe M.]
  • Relevance of new psychotropic drugs for the neurologist - [.]
  • Prevalence and impact of depression and pain in neurology outpatients - [Williams LS, Jones WJ, Shen J, Robinson RL, Weinberger M, Kroenke K.]
  • Prescribed drugs and neurological complications - [Grosset KA, Grosset DG.]
  • Functional symptoms in neurology-questions and answers - [Reuber M, Mitchell AJ, Howlett SJ, Crimlisk HL, Grünewald RA.]
  • Neuropsychiatric Complications After Liver Transplantation Role of Immunosuppression and Hepatitis C - [Tombazzi CR, Waters B, Shokouh-Amiri MH, Vera SR, Riely CA.]
  • Neuropathic pain a practical guide for the clinician - [.]
  • Atypical antipsychotics in bipolar depression-Neurobiological basis and clinical implications - [Brugue E, Vieta E]
  • A Case of Multiple Sclerosis Masked by Depression and Diabetic Neuropathy - [Schilling M, Brueckner-Totonji C, Arolt V, Baune BT.]
  • Multifunctional drugs with different CNS targets for neuropsychiatric disorders - [Van der Schyf CJ, Geldenhuys WJ, Youdim MB.]
  • Effects of Serotonin (5-Hydroxytryptamine, 5-HT) Reuptake Inhibition Plus 5-HT2A Receptor Antagonism on the Firing Activity of Norepinephrine Neurons - [Szabo ST, Blier P.]
  • The functional anxtomy neurochemistry,and pgarmacology of anxiety - [Ninan PT.]
  • Effect of Subchronic Antidepressant Treatments on Behavioral, Neurochemical, and Endocrine Changes in the Forced-Swim Test - [Thomas J. Connor, Padraig Kelliher, Yan Shen, Andrew Harkin, John P. Kelly and Brian E. Leonard]
  • Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment - [N. Brunello, J. A. den Boer, L. L. Judd, S. Kasper, J. E. Kelsey, M. Lader, Y. Lecrubier, J. P. Lepine, R. B. Lydiard, J. Mendlewicz, et al.]
  • A Single Dose of the Serotonin Neurotransmission Agonist Paroxetine Enhances Motor Output: Double-Blind, Placebo-Controlled, fMRI Study in Healthy Subjects - [Isabelle Loubinoux, Jérémie Pariente, Kader Boulanouar, Christophe Carel, Claude Manelfe, Olivier Rascol, Pierre Celsis and Fran?ois Chollet]
  • Morphine, cocaine and antidepressant induced motivational activity and midbrain dopaminergic neurotransmission - [Paul N Deslandes, David M Pache, Paul Buckland and Robert D.E Sewell]
  • Neurosteroid secretion in panic disorder - [Francesca Brambilla, Giovanni Biggio, Maria Giuseppina Pisu, Laura Bellodi, Giampaolo Perna, Vesna Bogdanovich-Djukic, Robert H. Purdy and Mariangela Serra]
  • Brain neurosteroid changes after paroxetine administration in mice - [Allon Nechmad, Rachel Maayan, Baruch Spivak, Edward Ramadan, Michael Poyurovsky and Abraham Weizman]
  • The spectra of neurasthenia and depression: course stability and transitions - [Gamma A, Angst J, Ajdacic V, Eich D, R?ssler W.]
  • Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia - [Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P.]
  • Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder - [Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P.]
  • Neurobiology of Depression in Stroke Patients - [Friedman, Ernest H.]
  • NEUROANATOMICAL CORRELATES OF DEPRESSION FOLLOWING STROKE - [Singh, A. M.; Black, S. E.; Herrmann, N. M.; Leibovitch, F. S.; Ebert, P. L.; Lawrence, J. R.; Szalai, J. P.]
  • Functional and Neuroanatomic Correlations in Poststroke Depression: The Sunnybrook Stroke Study - [Singh, Anu M.; Black, Sandra E.; Herrmann, Nathan M.; Leibovitch, Farrell S.; Ebert, Patricia L.; Lawrence, Joanne R.; Szalai, John P.]
  • Neurobiology of Depressive Symptoms Predictive of Stroke Among Japanese: Response - [Ohira, Tetsuya M.; Iso, Hiroyasu M.]
  • Early Depressive Symptoms After Stroke: Neuropsychological Correlates and Lesion Characteristics: P82 - [Kappelle, L. J.; Nys, Gudrun M.; van, Zandvoort Martine; van, Worp H.; de, Kort Paul; Jansen, Ben P.; de, Haan Edward]
  • Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke - [Rickards, H.]
  • Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis - [Atulkumar Ramaiya 1, James H. Johnson 2, H. Thomas Karnes 1 * AD:1Department of Pharmacy & Pharmaceutics, Medical College of Virginia/Virginia Commonwealth University, P.O. Box 980533, Richmond, Virginia 23298-980533.2Department of Anatomy, Medical Colleg]
  • Neurotransmitter transporters: fruitful targets for CNS drug discovery - [L Iversen]
  • Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly - [S Govoni1, M Racchi1, E Masoero1, M Zamboni2 and L Ferini-Strambi2]
  • Clinical Neurochemical Implications of Sleep Deprivation's Effects on the Anterior Cingulate of Depressed Responders - [Joseph C Wu1 MD, Monte Buchsbaum2 MD and William E Bunney Jr1 MD]
  • Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue - [Javier Angulo, Concepción Peiró, Carlos F Sanchez-Ferrer, Sonia Gabancho, Pedro Cuevas, Sandeep Gupta, I?igo Sáenz de Tejada]
  • The influence of neurocognitive dysfunctions on work capacity in schizophrenia patients a systematic review of the literature - []
  • Neurocognitive Deterioration in Elderly Chronic Schizophrenia Patients With and Without PTSD - [Goodman C, Finkel B, Naser M, Andreyev P, Segev Y, Kurs R, Melamed Y, Bleich A.]
  • Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial-development,methodology,and rationale - [Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M.]
  • Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment - [Marcel D. Waldinger]
  • Antidepressants for the Treatment of Neuropathic Pain - [William E Cayley JR]
  • Cardiac anxiety in people with and without coronary atherosclerosis - [Craig D. Marker, Ph.D. 1, Cheryl N. Carmin, Ph.D. 2, Raymond L. Ownby, Ph.D. 3]
  • Treatment of depression-Prescribing patterns of Antidepressants in primary care in the UK - [Donoghue JM, Tylee A.]
  • Treatment of anxiety and depressive disorders in patients with cardiovascular disease - [Davies SJ, Jackson PR, Potokar J, Nutt DJ.]
  • The effects of memory, attention, and executive dysfunction on outcomes of depression in a primary care intervention trial the PROSPECT study - [Bogner HR, Bruce ML, Reynolds CF, Mulsant BH, Cary MS, Morales K, Alexopoulos GS.]
  • SSRIs are there differences in effectiveness in primary care - [.]
  • Selective serotonin reuptake inhibitors-Are there differences in effectiveness in primary care - [.]
  • Psychiatric Treatment in Primary Care Patients With Anxiety disorders-A comparison of care received from primary care providers and Psychiatrists - [Weisberg RB, Dyck I, Culpepper L, Keller MB.]
  • Primary Care  Managing Depression in Medical Outpatients - [Whooley MA, Simon GE.]
  • Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care systematic review and meta-analysis - [MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I]
  • Depression diagnosis and management for the primary care physician - [Ferguson JM.]
  • Depression and the risk for cardiovascular diseases-systematic review and meta analysis - [Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A.]
  • DEPRESSION IS ASSOCIATED WITH HIGHER MORTALITY IN PATIENTS WITH A HISTORY OF VENTRICULAR FIBRILLATIONTACHYCARDIA - [.]
  • Cognitive Function Impairment in Patients with Neuropathic Pain Under Standard Conditions of Care - [Povedano M, Gascón J, Gálvez R, Ruiz M, Rejas J.]
  • Cardiac vagal control in depression-A critical analysis - [Rottenberg J.]
  • Treatment of dysthymia and minor depression in primary care a randomized trial in patients aged 18 to 59 - [Barrett JE, Williams JW, Oxman TE, Frank E, Katon W, Sullivan M, Hegel MT, Cornell JE, Sengupta AS.]
  • Mixed anxiety-depression in a primary-care clinic - [Stein MB, Kirk P, Prabhu V, Grott M, Terepa M.]
  • Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care a randomized trial - [Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, Stang P, Zhou XH, Hays R, Weinberger M.]
  • Paroxetine, fluoxetine, and sertraline are equally effective in treating depression in primary care. - [.]
  • The Prevalence of Depression and Panic Disorder in Primary Care Patients with Musculoskeletal Complaints - [.]
  • The Clinical Significance of Subsyndromal Depression in Older Primary Care Patients - [Lyness JM, Kim J, Tang W, Tu X, Conwell Y, King DA, Caine ED.]
  • Correlates of Late-Life Major Depression A Comparison of Urban and Rural Primary Care Patients - [Friedman B, Conwell Y, Delavan RL.]
  • Childhood Anxiety in a Diverse Primary Care Population-Parent-Child Reports, Ethnicity and SCARED Factor Structure - [Wren FJ, Berg EA, Heiden LA, Kinnamon CJ, Ohlson LA, Bridge JA, Birmaher B, Bernal MP.]
  • A Qualitative Study of Depression in Primary Care-Missed Opportunities for Diagnosis and Education. - [Saver BG, Van-Nguyen V, Keppel G, Doescher MP.]
  • Bipolar disorder Improving diagnosis and optimizing integrated care - [.]
  • Bipolar Depression in Primary in primary care-A hidden threat - [Lewis FT.]
  • Bipolar Depression in a Low-Income Primary Care Clinic - [Olfson M, Das AK, Gameroff MJ, Pilowsky D, Feder A, Gross R, Lantigua R, Shea S, Weissman MM.]
  • Treating Patients With Bipolar Disorder in Primary Care - [.]
  • Management of anxiety(panic disorder,with or without agoraphobia,and generalized anxiety disorder)in adults in primary, secondary and community care - [.]
  • Status of minor depression or dysthymia in primary care following a randomized controlled treatment - [Thomas E. Oxman, James E. Barrett, Anjana Sengupta, Wayne Katon, John W. Williams, Ellen Frank and Mark Hegel]
  • Predictors of nonresponse to treatment in primary care patients with dysthymia - [Wayne Katon, Joan Russo, Ellen Frank, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell]
  • Correlates of remission in primary care patients treated for minor depression - [Ellen Frank, Paola Rucci, Wayne Katon, James Barrett, John W. Williams, Thomas Oxman, Mark Sullivan and John Cornell]
  • Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? - [Alejandra Pinto-Meza, Judith Usall, Antoni Serrano-Blanco, David Suárez and Josep Maria Haro]
  • Treating late-life depression with interpersonal psychotherapy in the primary care sector - [Schulberg HC, Post EP, Raue PJ, Have TT, Miller M, Bruce ML.]
  • The diagnosis and management of depression and anxiety in primary care the need for a different framework - [K S Jacob]
  • Screening for generalized anxiety disorder in geriatric primary care patients - [Wetherell JL, Birchler GD, Ramsdell J, Unützer J]
  • Resource use and costs associated with patients treated for depression in primary care - [Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, M?rtensson B, J?nsson B.]
  • Rational treatment choices for non-major depressions in primary care an evidence-based review - [Ackermann RT, Williams JW.]
  • Depression and the risk for cardiovascular diseases systematic review and meta analysis - [Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A.]
  • Anxiety disorders go untreated in primary care setting - []
  • Depression and the risk for cardiovascular diseases:systematic review and meta analysis - [Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A.]
  • The role of patient personality in the identification of depression in older primary care patients - [McCray LW, Bogner HR, Sammel MD, Gallo JJ.]
  • Postictal cardiovascular response predicts therapeutic efficacy of electroconvulsive therapy for depression - [Azuma H, Fujita A, Sato K, Arahata K, Otsuki K, Hori M, Mochida Y, Uchida M, Yamada T, Akechi T, Furukawa TA.]
  • The effects of cognitive behavior therapy on depression in older patients with cardiovascular risks - [Strachowski D, Khaylis A, Conrad A, Neri E, Spiegel D, Taylor CB.]
  • Residual Anxiety Symptoms in Depressed Primary Care Patients - [McIntyre RS, Konarski JZ, Soczynska JK, Kennedy SH.]
  • The challenge of depression in late life: Bridging science and service in primary care - [Gallo JJ, Coyne JC]
  • Treating major depression in primary care practice: An update of the agency for health care policy and research practice guidelines - [Dr. H.C. Schulberg, Western Psychiatric Inst. and Clinic, 3811 O]
  • Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial - [Dr. W. Katon, Department of Psychiatry, Univ. of Washington School of Med., Box 35-6560, Seattle, WA 98195; United States. E-Mail: wkaton@u.washington.edu.]
  • Impact of a collaborative pharmacy practice model on the treatment of depression in primary care - [Dr. P.R. Finley, Univ. of California at San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0622; United States.]
  • Diagnosis and management of depression in primary care: A clinical update and review - [Dr. R.A. Remick, Department of Psychiatry, St. Paul]
  • A Review of Postpartum Depression for the Primary Care Physician - [Dr. D.A. Seehusen, Department of Family Practice, Madigan Army Medical Center, Ft. Lewis, WA 98431; United States. E-Mail: dean.seehusen@nw.amedd.army.mil.]
  • Response, partial response, and nonresponse in primary care treatment of depression - [Dr. R. Swindle, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285; United States. E-Mail: swindle@lilly.com.]
  • Prevalence and predictors of depression treatment in an international primary care study - [Dr. G.E. Simon, Center for Health Studies, 1730 Minor Ave., Number 1600, Seattle, WA 98101; United States. E-Mail: simon.g@ghc.org.]
  • A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group - [Department of Psychiatry and Pharmacology, University of Ottawa, Ontario, Canada.]
  • Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care - [Oxford University Department of Psychiatry, Warneford Hospital, Oxford OX3 7BJ. lmmw@soton.ac.uk]
  • Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses - [Golding M, Kotlyar M, Carson SW, Hoyler S, Lazarus C, Davidson C, Guzzo J, Sontz E, Garbutt JC]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 [28] 29 30